No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US Stock MarketDetailed Quotes
IMTX Immatics
- 13.020
- +0.070+0.54%
Close Jun 14 16:00 ET
- 13.270
- +0.250+1.92%
Post 16:28 ET
1.34BMarket Cap-12376P/E (TTM)
13.365High12.647Low166.76KVolume12.870Open12.950Pre Close2.16MTurnover0.29%Turnover RatioLossP/E (Static)103.05MShares13.77052wk High3.11P/B754.30MFloat Cap7.15052wk Low--Dividend TTM57.93MShs Float18.420Historical High--Div YieldTTM5.54%Amplitude5.750Historical Low12.945Avg Price1Lot Size
Full Hours
- 5D
- 1D
- 1W
- 1M
- 1Q
- 1Y
Trade Overview
Unit: --
Capital Trend
IntradayDayWeekMonth
No Data
News
Here's Why We Think Immatics N.V.'s (NASDAQ:IMTX) CEO Compensation Looks Fair for the Time Being
Key Insights Immatics' Annual General Meeting to take place on 20th of June CEO Harpreet Singh's total compensation includes salary of €488.0k Total compensation is similar to the industry average
We're Hopeful That Immatics (NASDAQ:IMTX) Will Use Its Cash Wisely
We can readily understand why investors are attracted to unprofitable companies. For example, although software-as-a-service business Salesforce.com lost money for years while it grew recurring reve
12 Health Care Stocks Moving In Friday's Intraday Session
GainersInnovative Eyewear (NASDAQ:LUCY) shares increased by 328.8% to $0.8 during Friday's regular session. The market value of their outstanding shares is at $13.9 million. OneMedNet (NASDAQ:ONMD) sh
Here's Why We're Not Too Worried About Immatics' (NASDAQ:IMTX) Cash Burn Situation
Immatics Is Maintained at Buy by Mizuho
Immatics Is Maintained at Buy by Mizuho
Express News | Mizuho Maintains Buy on Immatics, Raises Price Target to $16
Comments
» Holdings: 87
» Holdings in Top 20: 86.71%
» Qtr over Qtr Change**: -9.29%
Top Holdings:
$Incyte(INCY.US$
$BeiGene(BGNE.US$
$ACADIA Pharmaceuticals(ACAD.US$
$Madrigal Pharmaceuticals(MDGL.US$
$Rhythm Pharmaceuticals(RYTM.US$
$Revolution Medicines(RVMD.US$
$Kymera Therapeutics(KYMR.US$
$AbCellera Biologics(ABCL.US$
$Bicycle Therapeutics(BCYC.US$
$Edgewise Therapeutics(EWTX.US$
$Immunocore(IMCR.US$
$Kodiak Sciences(KOD.US$
$Roivant Sciences(ROIV.US$
...
» Holdings in Top 20: 86.71%
» Qtr over Qtr Change**: -9.29%
Top Holdings:
$Incyte(INCY.US$
$BeiGene(BGNE.US$
$ACADIA Pharmaceuticals(ACAD.US$
$Madrigal Pharmaceuticals(MDGL.US$
$Rhythm Pharmaceuticals(RYTM.US$
$Revolution Medicines(RVMD.US$
$Kymera Therapeutics(KYMR.US$
$AbCellera Biologics(ABCL.US$
$Bicycle Therapeutics(BCYC.US$
$Edgewise Therapeutics(EWTX.US$
$Immunocore(IMCR.US$
$Kodiak Sciences(KOD.US$
$Roivant Sciences(ROIV.US$
...
6
$Immatics(IMTX.US$ Immatics Receives FDA Regenerative Medicine Advanced Therapy (RMAT) Designation For ACTengine IMA203 TCR-T Monotherapy![]()
Gapping up
News:
• $PyroGenesis Canada(PYR.US$ +5.9% (announces that the negotiation for the land-based system to destroy PFAS contract has been suspended and discontinued)
• $Immatics(IMTX.US$ +3.1% (announces a clinical data update for the IMA203)
• $iPath Series B S&P 500 VIX Short-Term Futures ETN(VXX.US$ +1.6% (rising with softness in futures)
• $Nevro(NVRO.US$ +1.4% (comments on $UnitedHealth(UNH.US$ medical coverage policy u...
News:
• $PyroGenesis Canada(PYR.US$ +5.9% (announces that the negotiation for the land-based system to destroy PFAS contract has been suspended and discontinued)
• $Immatics(IMTX.US$ +3.1% (announces a clinical data update for the IMA203)
• $iPath Series B S&P 500 VIX Short-Term Futures ETN(VXX.US$ +1.6% (rising with softness in futures)
• $Nevro(NVRO.US$ +1.4% (comments on $UnitedHealth(UNH.US$ medical coverage policy u...
8
Read more
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg
MARKET-TEST-DUMMYOP :